Peginterferon Alfa-2A
Pegasys
Interferon alpha
NADAC/unit
$1070.9040
Active Shortage
Tier 1: 35.9%
PA Req: 141.0%
vs. brand Pegasys: Generic saves up to -10609% per unit
Active Shortages
2025-01-24 Pegasys availability will become more limited through Q4 2025. Product replenishment is expected sometime in 2026 and before May 31, 2026., pharmaand GmbH (pharma&)
2025-01-24 Pegasys availability will become more limited through Q4 2025. Product replenishment is expected sometime in 2026 and before May 31, 2026., pharmaand GmbH (pharma&)
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.